How It Works

From Cheek Swab to Clear Next Steps

Four simple steps to personalized AMD risk assessment. No blood draw, no complex procedures — just clear answers.

Step 01

Order Your Kit

Order online or through your eye care provider. Kits can be shipped directly to your home or collected at your provider's office.

Secure online ordering

HIPAA-compliant data handling

Ships within 1–2 business days

Order Your Kit
Step 02

Collect Your Sample

A simple buccal (cheek) swab — painless and takes less than a minute. No blood draw, no needles, no fasting.

Painless cheek swab

Takes under 60 seconds

Can be done at home or in-office

Collect Your Sample
Step 03

Lab Analysis

Your sample is analyzed at our laboratory. We genotype 14 genetic markers across 12 genes including CFH, ARMS2, C3, and more.

14 genetic markers across 12 genes

Results delivered within 6–8 weeks

Lab Analysis
Step 04

Get Your Report

Receive a comprehensive report with a clear summary of your genetic risk, personalized recommendations, and actionable next steps.

Clear risk summary

Personalized recommendations

Evidence-linked next steps

Get Your Report
Your Report

Everything You Need in One Report

10-Year Risk for Progression to CNV or GA

0255075100TIME (Years)PROGRESSION RISK (%)251018%31%53%PatientPopulation Average

Genetic Risk Percentile

Patient's value: 36

LOW
0255075100
HIGH

Average Risk

Progression Risk to CNV or GA

18%

2-Year

31%

5-Year

53%

10-Year

Genetic Features

GeneSNPResultRisk
CFHrs3766405CC**
CFHrs412852CC**
ABCA1rs1883025CC**
APOErs7412CC-
APOErs429358CT*
ARMS2rs10490924GG-
C2rs9332739GG**
C3rs2230199CC-
CETPrs3764261CC-
CFBrs541862AA-
CFIrs10033900CT*
COL8A1rs13095226TT-
LIPCrs10468017CT*
TIMP3rs9621532AA**
Risk Legend:- Low* Medium** High

Non-Genetic Features

Risk ParameterValue
AMD Status ODEarly AMD
AMD Status OSEarly AMD
SmokingQuit
EducationHigh School or Greater
Height6' 2"
Weight220
BMI28

Supplement Recommendation based on CFH and ARMS2 genotyping

AREDS without Zinc

View Sample Report
Understanding Results

Risk Categories Explained

Lowest Risk

Lowest risk of progression. Standard annual comprehensive exam with imaging as indicated.

Lowest risk tier

Moderate Risk

Moderate risk. Enhanced monitoring recommended. Semi-annual exams with OCT imaging.

Moderate risk tier

High Risk

High risk of progression. Close monitoring with quarterly exams. Consider early intervention.

High risk tier

Highest Risk

Highest risk. Intensive monitoring protocol. Frequent imaging and proactive management.

Highest risk tier

Ready to Get Started?

Order a TestFor PatientsFor Professionals